SCHEMBL18615401

SCHEMBL18615401

C=CCc1cc(C(c2ccccc2)(c2ccccc2)c2ccc(OC3CCO3)c(CC=C)c2)ccc1OCC1CO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 6/20 0.36
GLA P06280 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
PTPN1 P18031 2/20 0.33
TP53 P04637 3/20 0.33
TSHR P16473 3/20 0.33
MAPT P10636 3/20 0.33
HPGD P15428 2/20 0.33
HIF1A Q16665 2/20 0.33
CYP1A2 P05177 1/20 0.33
PPARG P37231 1/20 0.33
CYP3A4 P08684 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
PTGDR Q13258 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
KDM4E B2RXH2 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18593752 0.93 MEN1 (0.45) MEN1KMT2AALDH1A1GLATDP1
SCHEMBL20785614 0.90 MEN1 (0.43) MEN1KMT2AALDH1A1GLATDP1
SCHEMBL19227254 0.89 MEN1 (0.42) MEN1KMT2AALDH1A1GLATDP1
SCHEMBL19224810 0.86 ALDH1A1 (0.45) MEN1KMT2AALDH1A1GLATDP1
SCHEMBL18615576 0.84 GABRA1 (0.42) MEN1KMT2AALDH1A1GLATDP1
SCHEMBL21579039 0.83 ALDH1A1 (0.42) MEN1KMT2AALDH1A1GLATDP1
SCHEMBL20781743 0.82 MEN1 (0.49) MEN1KMT2AALDH1A1GLATDP1
SCHEMBL20781740 0.82 GABRA1 (0.39) MEN1KMT2AALDH1A1GLATDP1
SCHEMBL19880368 0.80 TSHR (0.43) MEN1KMT2AALDH1A1GLAPTPN1
SCHEMBL18615398 0.80 PTPN1 (0.40) MEN1KMT2AALDH1A1GLATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597412-B2 Epoxy compound, mixture, composition, and cured product comprising same, method for preparing same, and use thereof KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2020-03-24 US disclosed
US-20170066789-A1 NOVEL EPOXY COMPOUND, MIXTURE, COMPOSITION, AND CURED PRODUCT COMPRISING SAME, METHOD FOR PREPARING SAME, AND USE THEREOF KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2017-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066789-A1 NOVEL EPOXY COMPOUND, MIXTURE, COMPOSITION, AND CURED PRODUCT COMPRISING SAME, METHOD FOR PREPARING SAME, AND USE THEREOF ESD, NOTUM, PFAS MEN1 3493/4885KMT2A 583/4885ALDH1A1 1180/4885
US-10597412-B2 Epoxy compound, mixture, composition, and cured product comprising same, method for preparing same, and use thereof ESD, NOTUM, GMNN MEN1 2851/4885KMT2A 477/4885ALDH1A1 1329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.